Details for New Drug Application (NDA): 021747
✉ Email this page to a colleague
The generic ingredient in COMBIVENT RESPIMAT is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 021747
Tradename: | COMBIVENT RESPIMAT |
Applicant: | Boehringer Ingelheim |
Ingredient: | albuterol sulfate; ipratropium bromide |
Patents: | 6 |
Pharmacology for NDA: 021747
Mechanism of Action | Adrenergic beta2-Agonists Cholinergic Antagonists |
Suppliers and Packaging for NDA: 021747
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COMBIVENT RESPIMAT | albuterol sulfate; ipratropium bromide | SPRAY, METERED;INHALATION | 021747 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0024 | 0597-0024-02 | 1 CARTRIDGE in 1 CARTON (0597-0024-02) / 120 SPRAY, METERED in 1 CARTRIDGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;INHALATION | Strength | EQ 0.1MG BASE/INH;0.02MG/INH | ||||
Approval Date: | Oct 7, 2011 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 26, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 10, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 13, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021747
Complete Access Available with Subscription